Stephen K. Tyring, MD, PhDSeptember 20, 2018

FDA 483 - Stephen K. Tyring, MD, PhD - September 20, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Stephen K. Tyring, MD, PhD

Record Details

An FDA inspection of Stephen K. Tyring, MD, PhD in Houston, TX, revealed significant deficiencies in clinical trial conduct. Observations included failure to follow the investigational plan regarding efficacy assessments and the use of medical scribes, leading to concerns about data integrity. Additionally, the firm failed to promptly report a serious adverse event to the trial sponsor as required by the protocol.

Company: Stephen K. Tyring, MD, PhD
Inspection Date: September 20, 2018
Product Type: Drugs
Office: Dallas District Office
Person: Zerita White (investigator)

Open in Dashboard

ID · 79c9f73b-4fd0-44db-a02a-043af1b7296b